《港股》恆指半日升457點 阿里美團中芯領漲 券商股熱炒
市場憧憬本月的中央政治局會議或會推出刺激政策,港股早市上升,恆指高開4點後升幅擴大,半日升457點或1.9%,報24,485點;國指升158點或1.8%,報8,827點;恆生科技指數升108點或2.1%,報5,324點。大市半日成交總額1,758.54億元。
科技股方面,阿里(09988.HK)、美團(03690.HK)及中芯(00981.HK)升3.1%至3.4%,嗶哩嗶哩(09626.HK)升2.6%,騰訊(00700.HK)及百度(09888.HK)升1.7%及1.2%,網易(09999.HK)及快手(01024.HK)升0.7%,據報京東(09618.HK)進軍短劇市場,京東低開1.4%倒升,半日升1.4%。
此外,商湯(00020.HK)炒高12%,微盟(02013.HK)及東方甄選(01797.HK)升6%及5.5%,中軟國際(00354.HK)及華虹(01347.HK)升3.8%及4.6%。丘鈦(01478.HK)預告上半年溢利大增1.5至1.8倍,股價升2.5%。舜宇(02382.HK)6月手機鏡頭出貨量按年跌12.7%,該股升0.5%。
小米汽車累計交付30萬輛,小米(01810.HK)升1.8%。蔚來(09866.HK)升7.2%,公司旗下樂道L90月底上市。其他車股方面,比亞迪(01211.HK)及小鵬(09868.HK)升2%及2.7%。
消費股上漲,九毛九(09922.HK)升4.8%,蒙牛(02319.HK)、潤飲(02460.HK)、海底撈(06862.HK)、海爾智家(06690.HK)、萬洲(00288.HK)、頤海(01579.HK)、潤啤(00291.HK)及攜程(09961.HK)升2.8%至3.5%。
醫藥股藥明康德(02359.HK)預告上半年歸屬股東淨利潤增1.02倍,股價升11.3%。同系藥明生物(02269.HK)升6%。康龍化成(03759.HK)及諾誠健華(09969.HK)升9.6%及6.9%。中生製藥(01177.HK)庫莫西利膠囊新適應症上市申請獲內地受理,股價高開1%後倒跌,半日跌0.8%。
穩定幣熱潮延伸至內地券商股,國泰海通(02611.HK)及中信建投(06066.HK)炒高16%及10.5%,中金(03908.HK)、廣發(01776.HK)、中信證券(06030.HK)及中國銀河(06881.HK)升6%至7.7%。中州證券(01375.HK)炒高65%。其他券商集體飆升,南華金融(00619.HK)及立橋(08350.HK)升47%及40%,時富投資(01049.HK)升26%,交銀國際(03329.HK)及申萬宏源香港(00218.HK)升16%及14%。
其他金融股方面,匯控(00005.HK)升1.3%,港交所(00388.HK)及友邦(01299.HK)升3.7%及3.5%。內險股太保(02601.HK)、中國平安(02318.HK)及衆安在線(06060.HK)升4.9%至5.8%,中國太平(00966.HK)及國壽(02628.HK)升逾3%。
金礦股招金(01818.HK)及紫金(02899.HK)升逾3%,資源股中鋁(02600.HK)升5.4%,洛鉬(03993.HK)、江銅(00358.HK)及五礦資源(01208.HK)升3.4%至3.7%。
周傑倫概念巨星傳奇(06683.HK)半日升21.7%收15.7元,成交40.5億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.